Retinitis Pigmentosa News and Research

RSS
Retinitis pigmentosa (RP) is the name given to a group of inherited eye diseases that affect the retina (the light-sensitive part of the eye). RP causes the breakdown of photoreceptor cells (cells in the retina that detect light). Photoreceptor cells capture and process light helping us to see. As these cells breakdown and die, patients experience progressive vision loss. The most common feature of all forms of RP is a gradual breakdown of rods (retinal cells that detect dim light) and cones (retinal cells that detect light and color). Most forms of RP first cause the breakdown of rod cells. These forms of RP, sometimes called rod-cone dystrophy, usually begin with night blindness. Night blindness is somewhat like the experience normally sighted individuals encounter when entering a dark movie theatre on a bright, sunny day. However, patients with RP cannot adjust well to dark and dimly lit environments.
Encapsulated cell therapy could be new way to fight glaucoma

Encapsulated cell therapy could be new way to fight glaucoma

Research findings offer promising treatment target for blinding diseases

Research findings offer promising treatment target for blinding diseases

IU receives $1.9 million grant to investigate effects of congenital birth defects and age on the eye

IU receives $1.9 million grant to investigate effects of congenital birth defects and age on the eye

NanoScope awarded AGI Grant to re-sensitize photo-degenerated retinal areas with MCO

NanoScope awarded AGI Grant to re-sensitize photo-degenerated retinal areas with MCO

Research opens way towards making promising advances in retinal prostheses

Research opens way towards making promising advances in retinal prostheses

Interim results from clinical trial demonstrate safety of cell-based therapy for retinitis pigmentosa

Interim results from clinical trial demonstrate safety of cell-based therapy for retinitis pigmentosa

Shire’s Xiidra receives FDA approval for treating dry eye disease in adult patients

Shire’s Xiidra receives FDA approval for treating dry eye disease in adult patients

Pain reliever appears to help preserve vision in animal model of retinal degeneration

Pain reliever appears to help preserve vision in animal model of retinal degeneration

New study suggests how rod photoreceptors may have originated to give rise to nocturnal mammals

New study suggests how rod photoreceptors may have originated to give rise to nocturnal mammals

LALES study analyzes risk, prevalence of early and late stage AMD among Latinos

LALES study analyzes risk, prevalence of early and late stage AMD among Latinos

Pioneering gene therapy may lead to potential cure for common causes of vision loss

Pioneering gene therapy may lead to potential cure for common causes of vision loss

University’s blindness therapy comes a step closer following landmark licensing deal with US firm

University’s blindness therapy comes a step closer following landmark licensing deal with US firm

University's blindness therapy comes a step closer following landmark licensing deal with US firm

University's blindness therapy comes a step closer following landmark licensing deal with US firm

Leading entrepreneurs, innovators to take part in Royal Society of Medicine's 12th Medical Innovations Summit

Leading entrepreneurs, innovators to take part in Royal Society of Medicine's 12th Medical Innovations Summit

Retina Implant receives CE approval for latest Alpha AMS device

Retina Implant receives CE approval for latest Alpha AMS device

Amarantus BioScience Holdings closes $3M investment

Amarantus BioScience Holdings closes $3M investment

Study reveals another clue to workings of trachoma

Study reveals another clue to workings of trachoma

CUMC, Iowa scientists use CRISPR to repair genetic mutation responsible for retinitis pigmentosa

CUMC, Iowa scientists use CRISPR to repair genetic mutation responsible for retinitis pigmentosa

Shire announces resubmission of lifitegrast NDA to FDA for treatment of dry eye disease in adults

Shire announces resubmission of lifitegrast NDA to FDA for treatment of dry eye disease in adults

Incidence of childhood myopia has more than doubled over last 50 years among American children

Incidence of childhood myopia has more than doubled over last 50 years among American children